4,0
14 apr 2014
Dipendente attuale, più di 3 anni
Emeryville, CA
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Good track record of bringing therapy to patients
Svantaggi
The bottom line is the money being made for novarits, Basel and the board.